Brinter has been developing the granulate-based multi-material 3D printing process as part of the EU Horizon2020 project Novum. The increased concern of environmental issues and technology development has led to growing interest in developing novel, sustainable, yet high-performance materials for industrial additive manufacturing (AM) and for a wide variety of applications such as electrical insulation components and parts for the automotive, marine and medical industry. AM enables rapid and cost-effective manufacturing of complex and lightweight parts without any expensive tools such as moulds.

Widespread access to verifiably accurate, customized 3D anatomic modeling offers physicians fresh insights; connects clinicians and their patients with vital information

Brinter was thrilled to meet people in person and create new contacts at the Biocity Symposium with the title CANCER – BREAKING BAD in Turku last week. Finally, a partly physical and partly virtual scientific meeting could be arranged despite the COVID-19 situation and allowed us to demonstrate Brinter® 3D bioprinting platform in action! As you are aware, cancer research is one of Brinter’s core application areas.

Elisava students design outside the box with 3D printing

At Elisava, Barcelona School of Design and Engineering, Undergraduate Degree students have been utilizing 3D printing as a way of exploring different design possibilities and tremendously speeding up their processes.

Our partners from the RESTORE project have recently published an article titled “Design and development of poly-L/D-lactide copolymer and barium titanate nanoparticle 3D composite scaffolds using breath figure method for tissue engineering applications” in the journal Colloids and Surfaces B: Biointerfaces.

Our customer, the University of Helsinki, is participating in a joint two-year project called Go for Growth with Novel Stem Cell Platform to develop stem cell techniques to prevent brain diseases and to compile them into a competence base for the prediction, prevention and ultra-early diagnostics of brain diseases.

Millions of people worldwide are affected by osteoarthritis (OA), occurring due to the wear down of protective cartilage that cushions the end of bones. Cartilage is a firm, slippery tissue that enables nearly frictionless joint motion.

RESTORE aims to develop a smart nanobiomaterial-based solution capable to modulate the articular cartilage microenvironment from a state of limited capacity of repair towards one that enables true regeneration of both tissue structure and function. One approach is the development and validation of a nanoenabled COPLA® scaffold for cartilage repair.

The media and research firm Nanalyze has highlighted Brinter as one of the eight 3D Bioprinting Companies for Medical Solutions in their article published on June 17, 2021.

The aim of the EU funded project RESTORE is to treat osteoarthritis (OA) by generating functional cartilage through 3D bioprinting technology. A Swedish research team within RESTORE has now achieved a major scientific milestone in the treatment of OA; they have been able to generate functional cartilage tissue by 3D bioprinting chondrocytes into OA lesions.

Australian company Advanced Family & Sports Podiatry manufactures customized foot orthoses on the Sintratec S2 system. The 3D printer’s production capabilities allow Mark Ireland and his team to provide a timely and individualized treatment to their patients.

UpNano mimics natural tissue topography for biomedical research
The combination of a 2Photon 3D printer with an innovative hydrogel-based bio-ink enables direct printing of 3D structures with living cells at the meso and micro scale.